Effectiveness, Satisfaction, and Usability of Virtual Reality in the Management of Postoperative Pain in Patients Undergoing Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidad Francisco de Vitoria

About this trial

The goal of this clinical trial is to evaluate the effectiveness of using virtual reality glasses to reduce the need for rescue analgesia in patients with acute postoperative pain after knee arthroplasty.

The main questions it aims to answer are:

* What is the impact of virtual reality use on postoperative pain perception as measured by the Visual Analogue Scale (VAS)? * What potential adverse effects are associated with the use of virtual reality in the postoperative context? * What is the level of satisfaction and acceptance of virtual reality as a complementary strategy for pain management? * How does virtual reality influence quality of life and psychosocial variables in patients with acute postoperative pain after knee arthroplasty?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults ≥18 years of age, both sexes

Scheduled unilateral knee arthroplasty

Adequate cognitive and functional capacity to use virtual reality

Signed informed consent

Disqualifiers

Neurological or psychiatric disorders (history of epilepsy, seizures, psychosis, schizophrenia, claustrophobia, tremor, rigidity)

Significant visual or hearing impairments that hinder VR use

Physical or motor limitations preventing the use of VR headsets or maintaining the required posture

Score ≥4 on the 4AT delirium screening tool

Trial design

Design model

Parallel

Treatments tested in this trial

  • VIRTUAL REALITY

    Device

    Interactive VR Games: Participants use Meta Quest 3 head-mounted displays running a custom-developed VR application designed to elicit upper-limb and trunk movements. The application includes multiple structured scenarios: * Scenario 1 (Painting): Participants perform arm movements using handheld controllers to interact with a virtual painting environment. * Scenario 2 (Greenhouse): Participants move the arm to attract a butterfly, guide it toward a flower, and complete the assigned interaction task. * Scenario 3 (Aquarium): Participants perform bilateral arm movements to pop virtual bubbles. Immersive 360° Videos:Participants use Meta Quest 3 head-mounted displays to view immersive 360° relaxing videos (e.g., natural landscapes accompanied by calming background music).

Treatment groups

45 Participants
are divided into 3 treatment groups
Group A: CONTROLNo intervention 0 interventions
Group B: EXPERIMENTALExperimental treatment 1 intervention
Group C: PLACEBOPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain intensity (VAS)

Pain intensity is assessed using a 100-mm Visual Analogue Scale (VAS), ranging from "no pain" (0 mm, left anchor) to "worst imaginable pain" (100 mm, right anchor). Higher scores indicate greater pain intensity.

Time frame
Day 0 (day of intervention): pain measured at arrival to the ward and during three shifts (morning, afternoon, next-day morning), pre- and post conventional analgesia. If VR is used, pain is also measured immediately before and after each VR session.

Secondary outcomes

1

Sociodemographic variables

Age, weight, sex, and height recorded at enrollment

Time frame
Baseline
2

Analgesic medication use

Analgesic administration (scheduled analgesia and rescue medication) is extracted from the hospital electronic medical record (Selene). Date and time of each dose are recorded to determine whether the intervention reduces short-term analgesic requirements.

Time frame
From immediate postoperative period to 48 hours post-intervention.
3

Adverse events

All adverse events reported by participants or investigators are documented and classified by intensity ("mild," "moderate," "severe") and by relatedness to the intervention ("none," "unlikely," "possible," "definite")

Time frame
Throughout the intervention period and up to 48 hours post-intervention.
4

Satisfaction, Acceptability, and Perceived Safety (SEQ)

The Suitability Evaluation Questionnaire (SEQ) assesses satisfaction, acceptability, usability, and perceived safety of the VR system. It includes 13 items rated from 1 ("not at all" or "very easy") to 5 ("very much" or "very difficult"), plus one open-ended question on discomfort

Time frame
Immediately post-intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universidad Francisco de Vitoria

Lead sponsor

University of Castilla-La Mancha

Collaborator

Hospital Universitario del Sureste

Collaborator

This trial is not recruiting at the moment. You can still explore other options: